These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7746816)

  • 1. [Nasal transepithelial difference of potential in mucoviscidosis. Clinical application of the measurement].
    Maherzi A; Ategbo S; Pharaon I; Munck A; Cezard JP; Foucaud P; Navarro J
    Presse Med; 1995 Mar; 24(9):437-40. PubMed ID: 7746816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status of determining the transepithelial potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis].
    Unal-Maelger OH; Urbanek R
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):76-80. PubMed ID: 2452977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of nasal transepithelial potential difference (DDPTE) in cystic fibrosis. Analysis of a simplified measurement technique].
    Labbé A; Bellon G; Héraud MC; Arbre P; Goddon G; Alton E
    Arch Fr Pediatr; 1991 Nov; 48(9):617-20. PubMed ID: 1722389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of nasal transepithelial potential difference: a diagnostic test for cystic fibrosis].
    Charfi MR; Matran R; Regnard J; Lockhart A
    Rev Pneumol Clin; 1996; 52(1):9-13. PubMed ID: 8731749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
    Knowles M; Gatzy J; Boucher R
    N Engl J Med; 1981 Dec; 305(25):1489-95. PubMed ID: 7300874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional and modified nasal potential-difference measurement in cystic fibrosis.
    Höfmann T; Bohmer O; Hüls G; Terbrack HG; Bittner P; Klingmüller V; Heerd E; Lindemann H
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1908-13. PubMed ID: 9196094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic protocol for transepithelial nasal potential difference measurements.
    Schüler D; Sermet-Gaudelus I; Wilschanski M; Ballmann M; Dechaux M; Edelman A; Hug M; Leal T; Lebacq J; Lebecque P; Lenoir G; Stanke F; Wallemacq P; Tümmler B; Knowles MR
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():151-5. PubMed ID: 15463949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral digoxin, topical ouabain and salbutamol on transepithelial nasal potential difference in patients with cystic fibrosis.
    Peckham DG; Conn A; Chotai C; Lewis S; Knox AJ
    Clin Sci (Lond); 1995 Sep; 89(3):277-84. PubMed ID: 7493424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis.
    Sweezey NB; Smith D; Corey M; Ellis L; Carpenter S; Tullis DE; Durie P; O'Brodovich HM
    Pediatr Pulmonol; 2007 Jun; 42(6):519-24. PubMed ID: 17469152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transepithelial potential difference in cystic fibrosis.
    Hay JG; Geddes DM
    Thorax; 1985 Jul; 40(7):493-6. PubMed ID: 4035615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
    Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
    Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test.
    Delmarco A; Pradal U; Cabrini G; Bonizzato A; Mastella G
    Eur Respir J; 1997 May; 10(5):1145-9. PubMed ID: 9163660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced exhaled NO is related to impaired nasal potential difference in patients with cystic fibrosis.
    Texereau J; Fajac I; Hubert D; Coste J; Dusser DJ; Bienvenu T; Dall'Ava-Santucci J; Dinh-Xuan AT
    Vascul Pharmacol; 2005 Dec; 43(6):385-9. PubMed ID: 16182611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal potential difference: a clinical diagnostic test for cystic fibrosis.
    Alton EW; Currie D; Logan-Sinclair R; Warner JO; Hodson ME; Geddes DM
    Eur Respir J; 1990 Sep; 3(8):922-6. PubMed ID: 2292287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified technique for measurement of nasal transepithelial potential difference in infants.
    Southern KW; Noone PG; Bosworth DG; Legrys VA; Knowles MR; Barker PM
    J Pediatr; 2001 Sep; 139(3):353-8. PubMed ID: 11562613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exercise on the nasal transmucosal potential difference in patients with cystic fibrosis and normal subjects.
    Alsuwaidan S; Li Wan Po A; Morrison G; Redmond A; Dodge JA; McElnay J; Stewart E; Stanford CF
    Thorax; 1994 Dec; 49(12):1249-50. PubMed ID: 7878563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of transepithelial potential difference measurements in cystic fibrosis.
    Sauder RA; Chesrown SE; Loughlin GM
    J Pediatr; 1987 Sep; 111(3):353-8. PubMed ID: 2442338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.